Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rodger

Showing results (271-280 of 295) with videos related to

Pageof 30
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiencyJ P Galanaud, C A Holcroft, M A Rodger, et al.
Thrombosis and Haemostasis|May 12, 2010
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort studyMark A Crowther, David Garcia, Walter Ageno, et al.
Blood Advances|June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolismPhilip S Wells, Tobias Tritschler, Faizan Khan, et al.
Systematic Reviews|June 28, 2014
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)Marc A Rodger, Nicole J Langlois, Johanna Ip de Vries, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2025
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous ThromboembolismDuale Omar, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Annals of Internal Medicine|March 5, 2009
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trialMark A Crowther, Walter Ageno, David Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2025
Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative studyLauren Andrew, Alexandra Garven, Taryn S Taylor, et al.
The Lancet. Haematology|January 19, 2025
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trialLeslie Skeith, A Kinga Malinowski, Darine El-Chaâr, et al.
Annals of Internal Medicine|June 5, 2013
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialDavid R Anderson, Michael J Dunbar, Eric R Bohm, et al.
Lancet (London, England)|October 11, 2016
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trialsMarc A Rodger, Jean-Christophe Gris, Johanna I P de Vries, et al.
Pageof 30

Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiencyJ P Galanaud, C A Holcroft, M A Rodger, et al.
Thrombosis and Haemostasis|May 12, 2010
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort studyMark A Crowther, David Garcia, Walter Ageno, et al.
Blood Advances|June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolismPhilip S Wells, Tobias Tritschler, Faizan Khan, et al.
Systematic Reviews|June 28, 2014
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)Marc A Rodger, Nicole J Langlois, Johanna Ip de Vries, et al.
Journal of Thrombosis and Haemostasis : JTH|August 6, 2025
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous ThromboembolismDuale Omar, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Annals of Internal Medicine|March 5, 2009
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trialMark A Crowther, Walter Ageno, David Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2025
Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative studyLauren Andrew, Alexandra Garven, Taryn S Taylor, et al.
The Lancet. Haematology|January 19, 2025
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trialLeslie Skeith, A Kinga Malinowski, Darine El-Chaâr, et al.
Annals of Internal Medicine|June 5, 2013
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialDavid R Anderson, Michael J Dunbar, Eric R Bohm, et al.
Lancet (London, England)|October 11, 2016
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trialsMarc A Rodger, Jean-Christophe Gris, Johanna I P de Vries, et al.
Pageof 30